These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 17478498)

  • 41.
    Lam C; Gilliam KM; Rodden LN; Schadt KA; Lynch DR; Bidichandani S
    J Med Genet; 2023 Aug; 60(8):797-800. PubMed ID: 36635061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stalled DNA Replication Forks at the Endogenous GAA Repeats Drive Repeat Expansion in Friedreich's Ataxia Cells.
    Gerhardt J; Bhalla AD; Butler JS; Puckett JW; Dervan PB; Rosenwaks Z; Napierala M
    Cell Rep; 2016 Aug; 16(5):1218-1227. PubMed ID: 27425605
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epigenetic therapy for Friedreich ataxia.
    Soragni E; Miao W; Iudicello M; Jacoby D; De Mercanti S; Clerico M; Longo F; Piga A; Ku S; Campau E; Du J; Penalver P; Rai M; Madara JC; Nazor K; O'Connor M; Maximov A; Loring JF; Pandolfo M; Durelli L; Gottesfeld JM; Rusche JR
    Ann Neurol; 2014 Oct; 76(4):489-508. PubMed ID: 25159818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich's ataxia patients and in a mouse model.
    Rai M; Soragni E; Chou CJ; Barnes G; Jones S; Rusche JR; Gottesfeld JM; Pandolfo M
    PLoS One; 2010 Jan; 5(1):e8825. PubMed ID: 20098685
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel deletion-insertion mutation identified in exon 3 of FXN in two siblings with a severe Friedreich ataxia phenotype.
    Evans-Galea MV; Corben LA; Hasell J; Galea CA; Fahey MC; du Sart D; Delatycki MB
    Neurogenetics; 2011 Nov; 12(4):307-13. PubMed ID: 21830088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Friedreich ataxia: Detection of GAA repeat expansions and frataxin point mutations.
    Pandolfo M
    Methods Mol Med; 2006; 126():197-216. PubMed ID: 16930014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methylated and unmethylated epialleles support variegated epigenetic silencing in Friedreich ataxia.
    Rodden LN; Chutake YK; Gilliam K; Lam C; Soragni E; Hauser L; Gilliam M; Wiley G; Anderson MP; Gottesfeld JM; Lynch DR; Bidichandani SI
    Hum Mol Genet; 2021 Feb; 29(23):3818-3829. PubMed ID: 33432325
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Friedreich's ataxia: new insights.
    Krasilnikova MM; Humphries CL; Shinsky EM
    Emerg Top Life Sci; 2023 Dec; 7(3):313-323. PubMed ID: 37698160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological screening using an FXN-EGFP cellular genomic reporter assay for the therapy of Friedreich ataxia.
    Li L; Voullaire L; Sandi C; Pook MA; Ioannou PA; Delatycki MB; Sarsero JP
    PLoS One; 2013; 8(2):e55940. PubMed ID: 23418481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Comprehensive Transcriptome Analysis Identifies FXN and BDNF as Novel Targets of miRNAs in Friedreich's Ataxia Patients.
    Misiorek JO; Schreiber AM; Urbanek-Trzeciak MO; Jazurek-Ciesiołka M; Hauser LA; Lynch DR; Napierala JS; Napierala M
    Mol Neurobiol; 2020 Jun; 57(6):2639-2653. PubMed ID: 32291635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of human frataxin is regulated by transcription factors SRF and TFAP2.
    Li K; Singh A; Crooks DR; Dai X; Cong Z; Pan L; Ha D; Rouault TA
    PLoS One; 2010 Aug; 5(8):e12286. PubMed ID: 20808827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Friedreich's Ataxia: from the (GAA)n repeat mediated silencing to new promising molecules for therapy.
    Marmolino D; Acquaviva F
    Cerebellum; 2009 Sep; 8(3):245-59. PubMed ID: 19165552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterising the neuropathology and neurobehavioural phenotype in Friedreich ataxia: a systematic review.
    Corben LA; Georgiou-Karistianis N; Bradshaw JL; Evans-Galea MV; Churchyard AJ; Delatycki MB
    Adv Exp Med Biol; 2012; 769():169-84. PubMed ID: 23560311
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rational selection of small molecules that increase transcription through the GAA repeats found in Friedreich's ataxia.
    Grant L; Sun J; Xu H; Subramony SH; Chaires JB; Hebert MD
    FEBS Lett; 2006 Oct; 580(22):5399-405. PubMed ID: 16989817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differences in the determinants of right ventricular and regional left ventricular long-axis dysfunction in Friedreich ataxia.
    Peverill RE; Donelan L; Corben LA; Delatycki MB
    PLoS One; 2018; 13(12):e0209410. PubMed ID: 30596685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pitfalls in molecular diagnosis of Friedreich ataxia.
    Barcia G; Rachid M; Magen M; Assouline Z; Koenig M; Funalot B; Barnerias C; Rötig A; Munnich A; Bonnefont JP; Steffann J
    Eur J Med Genet; 2018 Aug; 61(8):455-458. PubMed ID: 29530802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene-based approaches toward Friedreich ataxia therapeutics.
    Hebert MD; Whittom AA
    Cell Mol Life Sci; 2007 Dec; 64(23):3034-43. PubMed ID: 17828464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Friedreich ataxia with GAA repeat expansion: molecular mechanism and clinical feature].
    Tanaka H
    Nihon Rinsho; 1999 Apr; 57(4):960-6. PubMed ID: 10222797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lentivirus-meditated frataxin gene delivery reverses genome instability in Friedreich ataxia patient and mouse model fibroblasts.
    Khonsari H; Schneider M; Al-Mahdawi S; Chianea YG; Themis M; Parris C; Pook MA; Themis M
    Gene Ther; 2016 Dec; 23(12):846-856. PubMed ID: 27518705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic silencing in Friedreich ataxia is associated with depletion of CTCF (CCCTC-binding factor) and antisense transcription.
    De Biase I; Chutake YK; Rindler PM; Bidichandani SI
    PLoS One; 2009 Nov; 4(11):e7914. PubMed ID: 19956589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.